Blog

A New Dawn in Lupus Treatment: The Promise of Topical RNA Therapeutics Systemic Lupus Erythematosus (SLE) is a debilitating autoimmune disease that has long puzzled researchers and clinicians. However, a groundbreaking development from the Hudson Institute of Medical Research in Melbourne offers a glimmer of hope. Researchers have developed a novel RNA-based topical cream that has shown remarkable potential in a world-first clinical trial, a finding that could revolutionize how we approach not just lupus, but a range of autoimmune disorders. This innovative approach, which leverages single-cell RNA sequencing to understand the disease at a molecular level, is paving the way for a new era of …